Journal Article Summary
The article investigates the purchasing patterns of rhinitis treatments in Australia, focusing on both prescription and over-the-counter (OTC) medications among patients with and without additional respiratory diseases like asthma or COPD. Understanding these patterns is crucial because rhinitis is a common condition that can significantly impact patients' quality of life and is often linked to other respiratory issues. The study aims to provide insights into how patients manage their rhinitis symptoms and the effectiveness of current treatment strategies, which is essential for improving patient care and outcomes.
The research analyzed pharmacy-related claims data from 909 pharmacies across Australia over a two-year period, examining a total of over 4 million transactions involving rhinitis treatments. The findings revealed that most purchases were single therapies, with oral antihistamines being the most common choice. Patients with both rhinitis and asthma/COPD were more likely to purchase multiple therapies, particularly combinations of oral antihistamines and intranasal corticosteroids. Geographical differences were noted, with variations in OTC purchases across different Australian regions, indicating that access to medications and patient behavior may differ based on location.
Despite the study's strengths, such as its large sample size and real-world data collection, there are limitations to consider. The cross-sectional design means that it cannot establish causality, and the lack of demographic details may affect the interpretation of the results. Patients should discuss their rhinitis management with healthcare professionals, especially regarding the appropriate use of medications like intranasal corticosteroids, which are underutilized despite being recommended as first-line treatments. Engaging with pharmacists for advice on OTC options can also enhance treatment effectiveness and safety.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Price David B, Smith Pete K, Harvey Richard John, Carney A Simon, Kritikos Vicky, Bosnic-Anticevich Sinthia Z, Christian Louise, Skinner Derek, et al.. Real-life treatment of rhinitis in Australia: a historical cohort study of prescription and over-the-counter therapies for patients with and without additional respiratory disease. Pragmatic and Observational Research 2018. DOI: 10.2147/POR.S153266. PMID: 30147391. PMCID: PMC6101013.
Featured Pill Pals Product
Azelastine Nasal Solution One Percent (1%) 30 ml --- Generic For Astelin --- 137 mcg --- 200 Metered Sprays --- Apotex Pharma
Azelastine Nasal Solution One Percent (1%) 30 ml — Generic For Astelin — 137 mcg — 200 Metered Sprays — Apotex Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
